CD8A and cancer: All in all, our data suggest a key interaction between cDC1 and a small subpopulation of TRM CD8+ T-cells that has been reported to exert a tumor-reactive function in the TME of several cancer types including HNC, but also ovarian, lung, and colon cancer (63).